Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Researchers at the Skaggs School of Pharmacy & Pharmaceutical Sciences at the University of California, San Diego, will work with Johnson & Johnson’s Janssen R&D unit to identify new treatments for Chagas disease, a parasitic infection that is the leading cause of heart failure in Latin America. Janssen will provide a team led by Skaggs Dean James McKerrow access to its Jump-Starter library of screening compounds. McKerrow will use the school’s new robotic screening facility to test the compounds for their ability to kill the parasite.
This article has been sent to the following recipient: